Feedback / Questions
liraglutide (4P004) - 4P-Pharma
https://www.businesswire.com/news/home/20250407335930/en/4Moving-Biotech-Secures-%E2%82%AC7.6M-France-2030-Grant-for-Pioneering-First-In-Class-Disease-Modifying-Osteoarthritis-Drug
Apr 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next